NasdaqGS:PODDMedical Equipment
Insulet (NasdaqGS:PODD) Launches Omnipod 5 iPhone App With Dexcom G7 Compatibility
Insulet (NasdaqGS:PODD) recently announced that its Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring System, enhancing its Automated Insulin Delivery capabilities. Over the last quarter, the company's share price increased by 20%, reflecting investor enthusiasm likely spurred by product advancements and strategic moves, such as new executive leadership under CEO Ashley McEvoy. These developments, alongside optimistic revenue guidance and expanded...